Deltex Medical
Chris joined the board in June 2015 and brings over 30 years of experience in Fortune 500 and VC funded healthcare companies in both the UK and importantly throughout the US. Executive Chairman of GADxLtd, Chairman of Global Access Health Ltd, and Non-executive Director of MediSieve, Causeway Therapeutics and Health Enterprise East, Mr Jones is a US national who came to the UK in 2008 to become CEO of GlySure. Prior to joining GlySure he was CEO of Tensys Medical developing and commercialising a novel continuous, non-invasive blood pressure monitor resulting in the sale of the company in 2008. Mr Jones also spent nine years with Nellcor Inc, a division of Tyco Healthcare, most recently as VP of Marketing responsible for the $700M WW pulse oximetry and critical care businesses. Mr Jones is a graduate of Yale University with a Bachelor of Science Degree in Molecular Biophysics and Biochemistry.
This person is not in the org chart
This person is not in any offices
Deltex Medical
Deltex Medical is a global leader in hemodynamic monitoring technology. Its unique oesophageal Doppler monitoring (ODM) platform delivers accurate, real-time information to guide anesthetists on the administration of fluid and drugs in surgical patients.